18 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
and checkpoints will ensure the project aligns with our strategic goals and the evolving landscape of pharmaceutical development.
MIRA-55
Our goal … and, accordingly, may not achieve our research, development and commercialization goals.
Our product candidates, if approved, may be unable to achieve
10-Q
2023 Q2
MIRA
Mira Pharmaceuticals Inc
15 Sep 23
Quarterly report
4:45pm
will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions
424B4
dqtryv8ao0 16
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
bocz 4vdmx
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-99.3
ecr8 78h78t0
29 Jun 23
IPO registration
4:39pm
S-1
r116an2cp7
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.1
n22vs
29 Jun 23
IPO registration
4:39pm
S-1
EX-14.1
ne8r5s4zigtqd1qzist
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-99.3
waggktrw
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
buq03kf7vz w4pg9c
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
xykn8iw so9vedcv6i7
2 May 23
Draft registration statement (amended)
12:00am
DRS
dm9gzl
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next